Cybin email design inspirations, newsletters, and email subjects

Filter
Date
More

Domains

Add a Domain or Brand

Mails

Total result: 56
Page
of 1
A $10 Price Target is only one reason to put this biotech NYSE stock on your radar.
stocksearning.com
A $10 Price Target is only one reason to put this biotech NYSE stock on your radar.
Sent On

15/03/2024

Investor Opportunity: FDA Green-Light for NYSE Psychedelic Stock
stockearnings.com
Investor Opportunity: FDA Green-Light for NYSE Psychedelic Stock
Sent On

08/03/2024

This quietly trading NYSE psychedelic company has an FDA green light clearance under its belt and a highly anticipated study is on the way!
stocksearning.com
This quietly trading NYSE psychedelic company has an FDA green light clearance under its belt and a highly anticipated study is on the way!
Sent On

08/03/2024

What Will 2024 Bring?
wealthdaily.com
What Will 2024 Bring?
Sent On

22/11/2023

“Unprecedented Results” From Psilocybin Trial
wealthdaily.com
“Unprecedented Results” From Psilocybin Trial
Sent On

01/11/2023

Cybin (NEO:CYBN) Acquires DMT Clinical Study from Entheon Biomedical
stockhouse.com
Cybin (NEO:CYBN) Acquires DMT Clinical Study from Entheon Biomedical
Sent On

07/06/2022

Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain
stockhouse.com
Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain
Sent On

09/05/2022

Taking ketamine for science
bloombergbusiness.com
Taking ketamine for science
Sent On

09/05/2022

Filament Health And Cybin Therapeutics Announce Approval For Phase II Clinical Trial For Depression
stockhouse.com
Filament Health And Cybin Therapeutics Announce Approval For Phase II Clinical Trial For Depression
Sent On

31/01/2022

Inching Towards A Potential Breakout, (LEXTF) Trends Green Early On More Breaking MOU News
fierceanalyst.net
Inching Towards A Potential Breakout, (LEXTF) Trends Green Early On More Breaking MOU News
Sent On

12/01/2022

Low Float Biotech Profile (LEXTF) Needs Your Complete Focus Based On 4 Potential Catalysts (Big MOU News)
fierceanalyst.net
Low Float Biotech Profile (LEXTF) Needs Your Complete Focus Based On 4 Potential Catalysts (Big MOU News)
Sent On

12/01/2022

Announcing An MOU Monday, This Low Float Biotech Idea (LEXTF) Requires Complete Attention Today
fierceanalyst.net
Announcing An MOU Monday, This Low Float Biotech Idea (LEXTF) Requires Complete Attention Today
Sent On

12/01/2022

(LEXTF) Is A New Biotech Breakout Idea With 4 Potential Catalysts Including A Recent Uplisting
fierceanalyst.net
(LEXTF) Is A New Biotech Breakout Idea With 4 Potential Catalysts Including A Recent Uplisting
Sent On

12/01/2022

Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine)
stockhouse.com
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine)
Sent On

17/12/2021

Investor Alert: New Biotech Uplists To NYSE
zacks.com
Investor Alert: New Biotech Uplists To NYSE
Sent On

24/08/2021

The Deep Woods: What I Learned from Shaq
eaglefinancialpublications.com
The Deep Woods: What I Learned from Shaq
Sent On

18/08/2021

Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion
stockhouse.com
Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion
Sent On

17/08/2021

Free Report: Early Entry into this Biotech Breakthrough
eaglefinancialpublications.com
Free Report: Early Entry into this Biotech Breakthrough
Sent On

12/08/2021

The Deep Woods: Molecules From the Healing Gods
eaglefinancialpublications.com
The Deep Woods: Molecules From the Healing Gods
Sent On

11/08/2021

Just Released Biotech Alert
mail6-financialmediamarketing.com
Just Released Biotech Alert
Sent On

30/07/2021

Just Released Biotech Alert
mail7-financialmediamarketing.com
Just Released Biotech Alert
Sent On

30/07/2021

Just Released Biotech Alert
mail4-financialmediamarketing.com
Just Released Biotech Alert
Sent On

30/07/2021

Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
financialrecoveryservices.net
Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
theinvestortradenetwork.com
Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
3clktrk.com
Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
zacks.com
Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
mail4-financialmediamarketing.com
Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
mail7-financialmediamarketing.com
Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
3clktrk.com
Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
earnliveplay.com
Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
moneywealthmatters.com
Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American
Sent On

27/07/2021

Cybin Announces Conditional Listing Approval from NYSE American
stockhouse.com
Cybin Announces Conditional Listing Approval from NYSE American
Sent On

22/07/2021

This company has just received a hugely optimistic “BUY” rating …
valuewalk.com
This company has just received a hugely optimistic “BUY” rating …
Sent On

01/07/2021

Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
stockhouse.com
Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
Sent On

30/06/2021

This company has just received a hugely optimistic “BUY” rating ...
valuewalk.com
This company has just received a hugely optimistic “BUY” rating ...
Sent On

29/06/2021

New drug could end depression misery and creates unique investment opportunity
theinvestortradenetowrk.com
New drug could end depression misery and creates unique investment opportunity
Sent On

25/06/2021

Investment bank forecasts 518.5% gain for this disruptive biotech
theinvestortradenetowrk.com
Investment bank forecasts 518.5% gain for this disruptive biotech
Sent On

25/06/2021

Biotech breakthrough could end depression misery... potential profit opportunity
moneywealthmatters.com
Biotech breakthrough could end depression misery... potential profit opportunity
Sent On

25/06/2021

Breakthrough Biotech Company Wows Investors
zacks.com
Breakthrough Biotech Company Wows Investors
Sent On

23/06/2021

Breakthrough Biotech Company Wows Investors
mail4-financialmediamarketing.com
Breakthrough Biotech Company Wows Investors
Sent On

23/06/2021

Breakthrough Biotech Company Wows Investors
mail-financialmediamarketing.com
Breakthrough Biotech Company Wows Investors
Sent On

23/06/2021

Breakthrough Biotech Company Wows Investors
mail6-financialmediamarketing.com
Breakthrough Biotech Company Wows Investors
Sent On

23/06/2021

Breakthrough Biotech Company Wows Investors
mail7-financialmediamarketing.com
Breakthrough Biotech Company Wows Investors
Sent On

23/06/2021

Breakthrough Biotech Company Wows Investors
moneywealthmatters.com
Breakthrough Biotech Company Wows Investors
Sent On

23/06/2021

Own THIS Psychedelics Stock Before It Uplists to the Nasdaq
energyandcapital.com
Own THIS Psychedelics Stock Before It Uplists to the Nasdaq
Sent On

03/06/2021

Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003
stockhouse.com
Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003
Sent On

26/04/2021

CRFTF Update: Currently Up Approximately 33% This Morning, This Green Wave Profile Needs Your Attention
fierceanalyst.net
CRFTF Update: Currently Up Approximately 33% This Morning, This Green Wave Profile Needs Your Attention
Sent On

22/03/2021

(CRFTF) Could Be The Next Breakout Green Wave Idea With 4 Potential Driver Indicators Leading The Way
fierceanalyst.net
(CRFTF) Could Be The Next Breakout Green Wave Idea With 4 Potential Driver Indicators Leading The Way
Sent On

22/03/2021

Before Tomorrow's Opening Bell, Get (CRFTF) On Your Radar And Read Up On Its 4 Potential Driver Indicators
fierceanalyst.net
Before Tomorrow's Opening Bell, Get (CRFTF) On Your Radar And Read Up On Its 4 Potential Driver Indicators
Sent On

22/03/2021

4 Potential Driver Indicators Could Provide Breakout Fuel For Green Wave Idea (CRFTF)
fierceanalyst.net
4 Potential Driver Indicators Could Provide Breakout Fuel For Green Wave Idea (CRFTF)
Sent On

21/03/2021

Recent Game-Changing News Could Become Major Driver Indicators For Green Wave Profile (CRFTF)
fierceanalyst.net
Recent Game-Changing News Could Become Major Driver Indicators For Green Wave Profile (CRFTF)
Sent On

20/03/2021

Breaking News: Cybin Receives “BUY” Rating With C$8 Price Target
zacks.com
Breaking News: Cybin Receives “BUY” Rating With C$8 Price Target
Sent On

17/03/2021

Breaking News: Cybin Receives \
eaglefinancialpublications.com
Breaking News: Cybin Receives \"BUY\" Rating With C$8 Price Target
Sent On

16/03/2021

Cybin Inc. Announces Uplisting to OTCQB Venture Market
stockhouse.com
Cybin Inc. Announces Uplisting to OTCQB Venture Market
Sent On

03/03/2021

Cybin Announces Closing of Upsized Bought Deal Offering
stockhouse.com
Cybin Announces Closing of Upsized Bought Deal Offering
Sent On

04/02/2021

Cybin Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings
stockhouse.com
Cybin Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings
Sent On

14/12/2020

Total result: 56
Page
of 1
Can't find what you looking for? Tell us!

Copyright © 2019–2024 SimilarMail.